Profile

Malcolm Lim

Dr Malcolm Lim joined the ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals (AMTAR) in August 2024 as a Postdoctoral Research Fellow. His research interest spans cancer biology, biomarker discovery and theranostic nanomedicine. At AMTAR, Malcolm will apply his multidisciplinary expertise to explore radiobiology and radiation-induced biological responses and to advance targeted pharmaceuticals for challenging cancers.

Malcolm earned his PhD from the University of Queensland (UQ) in 2022. His research, conducted in the labs of Professors Sunil Lakhani and Kristofer Thurecht, involved evaluating the efficacy of using nanomedicine for precision delivery of chemo- or radiotherapeutics against biomarkers in brain metastases. For this work, he developed a clinically-relevant brain metastasis mouse model. His research was recognised with the UQ Dean’s Award for Outstanding Thesis 2022.

Prior to joining AMTAR, Malcolm served as a Postdoctoral Researcher where he investigated the molecular mechanisms underlying Early Breast Cancers at the Molecular Breast Pathology Lab, UQ-Centre for Clinical Research, under the mentorship of Professors Sunil Lakhani and Peter Simpson. Before his academic career, Malcolm had five years of experience as a histologist, which provided him with a broad skillset in the field.

Despite his early career stage, Malcolm’s research is well-documented in numerous publications in biomedical research journals, reflecting his passion to advancing cancer research.



View All People